Correlation Between LIWANLI Innovation and Synmosa Biopharma
Can any of the company-specific risk be diversified away by investing in both LIWANLI Innovation and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIWANLI Innovation and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LIWANLI Innovation Co and Synmosa Biopharma, you can compare the effects of market volatilities on LIWANLI Innovation and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIWANLI Innovation with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIWANLI Innovation and Synmosa Biopharma.
Diversification Opportunities for LIWANLI Innovation and Synmosa Biopharma
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between LIWANLI and Synmosa is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding LIWANLI Innovation Co and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and LIWANLI Innovation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIWANLI Innovation Co are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of LIWANLI Innovation i.e., LIWANLI Innovation and Synmosa Biopharma go up and down completely randomly.
Pair Corralation between LIWANLI Innovation and Synmosa Biopharma
Assuming the 90 days trading horizon LIWANLI Innovation Co is expected to generate 1.07 times more return on investment than Synmosa Biopharma. However, LIWANLI Innovation is 1.07 times more volatile than Synmosa Biopharma. It trades about 0.16 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.2 per unit of risk. If you would invest 2,140 in LIWANLI Innovation Co on August 30, 2024 and sell it today you would earn a total of 90.00 from holding LIWANLI Innovation Co or generate 4.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
LIWANLI Innovation Co vs. Synmosa Biopharma
Performance |
| Timeline |
| LIWANLI Innovation |
| Synmosa Biopharma |
LIWANLI Innovation and Synmosa Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LIWANLI Innovation and Synmosa Biopharma
The main advantage of trading using opposite LIWANLI Innovation and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIWANLI Innovation position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.| LIWANLI Innovation vs. ALi Corp | LIWANLI Innovation vs. Altek Corp | LIWANLI Innovation vs. Edimax Technology Co | LIWANLI Innovation vs. ITE Tech |
| Synmosa Biopharma vs. Tai Tung Communication | Synmosa Biopharma vs. Professional Computer Technology | Synmosa Biopharma vs. Cameo Communications | Synmosa Biopharma vs. Hannstar Display Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |